ArticleJournal of the National Cancer Institute2026
Ultraprocessed food intake and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study.
Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundUltraprocessed food (UPF) intake is associated with obesity. Despite obesity being a risk factor for postmenopausal breast cancer, evidence for an association between UPF and breast cancer is limited. Our objective was to assess the association between UPF intake and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study.
methodsParticipants reported dietary intake via a food frequency questionnaire at baseline in 1995-1996 and were followed through 2018. Food items were disaggregated into food codes and assigned Nova classification via database linkage. Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for quintiles of UPF (g (1000 kcal day-1)-1) and postmenopausal breast cancer risk overall, by estrogen receptor (ER) status, and type (invasive or ductal carcinoma in situ [DCIS]), with and without adjustment for body mass index (BMI).
resultsAmong 181 460 postmenopausal women, 14 484 were diagnosed with breast cancer over a median 21 years of follow-up. Median (interquartile range) UPF intake was 284.6 (191.1-466.6) g (1000 kcal day-1)-1. No associations between UPF intake and postmenopausal breast cancer risk overall (HRQ5 vs Q1 = 0.98, 95% CI = 0.93 to 1.03; P = .32 for trend), by ER status (ER+: HRQ5 vs Q1 = 1.01, 95% CI = 0.94 to 1.09; P = .95 for trend; ER-: HRQ5 vs Q1 = 1.02, 95% CI = 0.87 to 1.20; P = .58 for trend), or by type (invasive: HRQ5 vs Q1 = 0.98, 95% CI = 0.92 to 1.04; P = .14 for trend; DCIS HRQ5 vs Q1 = 1.00, 95% CI = 0.87 to 1.13; P = .26 for trend) were observed. Following BMI adjustment, inverse trends for overall (P = .03 for trend) and invasive (P = .01 for trend) breast cancer were observed. CONCLUSION(S): UPF intake was not associated with postmenopausal breast cancer in the NIH-AARP cohort. Inverse trends observed after adjusting for BMI are likely spurious, owing to overadjustment.
Indexed as
Identifiers
42015373What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.